Paul founded Intercytex in 1999 and is its Chief Scientific Officer. He has over 17 years of experience in the commercial development of cell therapies. Prior to founding Intercytex, he was VP Research at Organogenesis Inc. He joined the founders in 1987 as a staff scientist researching into collagen as part of the wound repair stimulant programme Apligraf® and he was later instrumental in its development, manufacture and methods of shipping. He is a principal inventor on several patents related to various regenerative medicines. Paul has a BSc in biochemistry from the University College of Wales, a doctorate in the chemical structure of skin from the University of Leeds and carried out post doctorate studies on collagen cross-linking in skin at the University of Manchester.